Pavan Kumar Chintamaneni

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Pharmaceutics

Drug development and industrial pharmacy

Nanomedicine (London, England)

RSC advances

Raghavendra Institute of Pharmaceutical Education

JSS College of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Raghavendra Institute of Pharmaceutical Education Jul 01 2019

India

Assistant Professor & Head :: Dept of Pharmaceutics

JSS COllege of Pharmacy, Ooty Dec 07 2015 - Apr 30 2019

India

Senior Research Fellow (DBT-SRF) :: Dept of Pharmacology

Aditya College of Pharmacy Jun 15 2012 - Nov 28 2015

India

Assistant Professor :: Pharmaceutics

Education History

JSS College of Pharmacy Jan 01 2016 - Nov 02 2019

India

PHD :: Pharmaceutical Sciences

Publications

Cláudia Viegas, Ana B Patrício, João M Prata, Akhtar Nadhman, Pavan Kumar Chintamaneni, Pedro Fonte
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics 15 (6) (2023)
Cláudia Viegas, Ana B Patrício, João M Prata, Akhtar Nadhman, Pavan Kumar Chintamaneni, Pedro Fonte
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics 15 (6) (2023)
Pavan Kumar Chintamaneni, Praveen Thaggikuppe Krishnamurthy, Sai Kiran S S Pindiprolu
Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease. RSC advances 11 (10) (2021)
Piyong Sola, Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni, Sai Kiran S S Pindiprolu, Mamta Kumari
Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson's disease management. Expert opinion on drug delivery 17 (8) (2020)
Sai Kiran S S Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Venkata Rao Ghanta, Pavan Kumar Chintamaneni
Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer. Nanomedicine (London, England) 15 (16) (2020)
Mahesh Thondawada, Ashish Devidas Wadhwani, Dhanabal S Palanisamy, Hanumant Singh Rathore, Ramesh C Gupta, Pavan Kumar Chintamaneni, Malay K Samanta, Anil Dubala, Sameer Varma, Praveen Thaggikuppe Krishnamurthy, Kuppusamy Gowthamarajan
An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. Drug development and industrial pharmacy 44 (7) (2018)
Sai Kiran S S Pindiprolu, Pavan Kumar Chintamaneni, Praveen Thaggikuppe Krishnamurthy, Kinnera Ratna Sree Ganapathineedi
Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells. Drug development and industrial pharmacy 45 (2) (2018)

Pavan Kumar Chintamaneni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pavan Kumar Chintamaneni